We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
The current BLUE market cap is 96.98M. The company's latest EPS is USD -2.4381 and P/E is -0.37.
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 70k | 63k | 2.38M | 6.89M | 12.39M |
| Operating Income | -84.78M | -76.57M | -84.49M | -85.3M | -84.73M |
| Net Income | -76.52M | 32.23M | 21.24M | -72.91M | -71.73M |
| Year End 31 December 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 54.58M | 44.67M | 257.2M | 31.31M | 3.6M |
| Operating Income | -572.02M | -814.83M | -623.05M | -563.26M | -389.09M |
| Net Income | -555.63M | -789.61M | -618.7M | -819.38M | -266.58M |
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 520.1M | 554.9M | 692.74M | 663.39M | 613.61M |
| Total Liabilities | 361.24M | 358.56M | 338M | 374.37M | 391.07M |
| Total Equity | 158.86M | 196.34M | 354.74M | 289.02M | 222.54M |
| Year End 31 December 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 2.24B | 1.73B | 1.78B | 593.8M | 554.9M |
| Total Liabilities | 357.77M | 442.43M | 426.2M | 219.52M | 358.56M |
| Total Equity | 1.89B | 1.28B | 1.36B | 374.28M | 196.34M |
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -296.68M | -352.95M | -86.64M | -159.36M | -221.21M |
| Investing | 147.21M | 250.45M | 82.14M | 89.08M | 151.16M |
| Financing | 54.37M | 54.25M | 130.46M | 130.01M | 129.97M |
| Year End 31 December 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -413.43M | -564.38M | -470.35M | -635.64M | -352.95M |
| Investing | -679.44M | 507.81M | -84.35M | 562.56M | 250.45M |
| Financing | 737.69M | 21.19M | 546.72M | -93.95M | 54.25M |
| Market Cap | 96.98M |
| Price to Earnings Ratio | -0.37 |
| Price to Sales Ratio | 27.36 |
| Price to Cash Ratio | 0.87 |
| Price to Book Ratio | 0.5 |
| Dividend Yield | - |
| Shares Outstanding | 109.34M |
| Average Volume (1 week) | 7.6M |
| Average Volume (1 Month) | 6.09M |
| 52 Week Change | -78.68% |
| 52 Week High | 5.53 |
| 52 Week Low | 0.8618 |
| Spread (Intraday) | 0.01 (0.78%) |
| Company Name | bluebird bio Inc |
| Address |
251 little falls drive wilmington, delaware 19808 |
| Website | https://www.bluebirdbio.com |
| Industry | biological pds,ex diagnstics (2836) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
